1 Min Read
Oct 15 (Reuters) -
* Mapp Biopharmaceutical says Ebola drug ZMapp granted orphan medicinal product designation by European Medicines Agency
* Mapp says EMA designation “another crucial step toward approval of ZMapp” (Reporting by UK bureau)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.